Biosimilar Pipeline Analysis Market
A biosimilar drug is any drug that is designed from or very similar to an authentic biological drug. There are two main areas in which this occurs. One is where the basic molecular structure of an authentic biological drug is mimicked and another is where a “substance” is mimicked that resembles an authentic drug. Some of the most recent drugs utilized to treat certain cancers are biosimilar drugs. This includes targeted therapies and immunotherapies. Target therapies include those that attack cancer cells while immunotherapy uses the body’s own immune system to fight cancer.
Biosimilar drugs are very different than traditional biological drugs as they are created by using living human genes, cells and proteins. These drugs represent a new class of drugs that have fewer side effects and are able to go through the same approval processes with the FDA (Food and Drug Administration).
Recent Developments:
Major players operating in the global biosimilar pipeline analysis market are focused on approval and launch of new products to expand their product portfolio. For instance, in December 2019, the U.S. Food and Drug Administration approved Avsola (infliximab-axxq), a biosimilar of Remicade, from Amgen Inc. indicated for the treatment of Crohn disease, ulcerative colitis, rheumatoid arthritis and other conditions.
Get COVID-19 Impact Analysis with This Sample Report – https://www.coherentmarketinsights.com/insight/request-sample/582
Global Biosimilar Pipeline Analysis Market: Drivers
High prevalence of cancer is expected to propel growth of the global biosimilar pipeline analysis market over the forecast period. For instance, according to the study, ‘Cancer statistics for adults aged 85 years and older, 2019’, published in ACS CA: A Cancer Journal for Clinicians, in August 2019, in 2019, the projected number of cancer cases and deaths was 140,690 and 103,250 respectively, among adults aged 85 years and older in the U.S.
Moreover, high biologics R&D investment is also expected to aid in growth of the market. For instance, the investment required for production of biologics is also high and can reach over US$ 500 million.
Global Biosimilar Pipeline Analysis Market: Opportunities
R&D of biosimilars is expected to offer lucrative growth opportunities for players in the global biosimilar pipeline analysis market. For instance, in December 2020, Alvotech and Japanese pharmaceutical company Fuji Pharma agreed on an extension on their exclusive strategic partnership for the commercialization of four biosimilar medicines in Japan.
Market Trends:
Major players operating in the global biosimilar pipeline analysis market are focused on approval and launch of new products to expand their product portfolio. For instance, in March 2020, Samsung Bioepis, the South Korea-based company, received approval for its 420 mg multi-dose vial of ONTRUZANT (trastuzumab-dttb), a biosimilar referencing HERCEPTIN i (trastuzumab), from the U.S. Food and Drug Administration.
To Get Industry Research PDF Brochure Here @ https://www.coherentmarketinsights.com/insight/request-pdf/582
Global Biosimilar Pipeline Analysis Market: Competitive Landscape
Major players operating in the global biosimilar pipeline analysis market include, Amgen Inc., AstraZeneca, Boehringer Ingelheim GmbH, Biocon, F. Hoffmann-La Roche Ltd, Kyowa Pharmaceutical Industry Co. Ltd., Merck & Co., Novartis AG, and Pfizer Inc.
Global Biosimilar Pipeline Analysis Market: Key Developments
Major players operating in the global biosimilar pipeline analysis market are focused on approval and launch of new products to expand their product portfolio. For instance, Teva Pharmaceuticals and Celltrion Healthcare announced the launch of their trastuzumab biosimilar Herzuma (trastuzumab-pkrb) for the treatment of breast and gastric cancer.
Similarly, in June 2019, the U.S. Food and Drug Administration approved ZIRABEV (bevacizumab-bvzr), a biosimilar to Avastin, from Pfizer Inc. indicated for the treatment of metastatic colorectal cancer, recurrent or metastatic non-squamous non-small cell lung cancer, recurrent or metastatic cervical cancer.
Global Biosimilar Pipeline Analysis Market: Segmentation By Product Type:
- Human Growth Hormone
- Insulin
- Interferon
- Peptides
- Monoclonal antibodies
- Others
By Services:
- Clinical Trials
- Contract Research and Manufacturing
By Technology:
- Electrophoresis
- Recombinant DNA Technology
- Chromatography
- Nuclear Magnetic Resonance Technology
- Bioassay
- Mass Spectrometry
- Western Blotting
By Application:
- Oncology Disease
- Auto immune Disease
- Blood Disease
- Growth Hormone Deficiencies
To Direct Purchase this Research Report – https://www.coherentmarketinsights.com/insight/buy-now/582
Table of Content:
- Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations - Market Overview
o Report Description
• Market Definition and Scope
o Executive Summary
• Market Snippet By Product Type
• Market Snippet By Application
• Market Snippet By Technology
• Market Snippet By End User
• Market Snippet By Region
o Coherent Opportunity Map (COM) - Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
• Drivers
• Restraints
• Market Opportunities
o Technological Trends
o PEST Analysis
o Impact Analysis - Global Biosimilar Pipeline Analysis Market, By Product Type, 2021 – 2028 (US$ Million)
o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Reagents & Consumables
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Software’s
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Instruments
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million) - Global Biosimilar Pipeline Analysis Market, By Application, 2021 – 2028 (US$ Million)
o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Genomics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Proteomics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Diagnostics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Drug Discovery
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million) - Global Biosimilar Pipeline Analysis Market, By Technology, 2021 – 2028 (US$ Million)
o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Microarrays
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Microfluidics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million) - Global Biosimilar Pipeline Analysis Market, By End User, 2021 – 2028 (US$ Million)
o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Hospitals
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Diagnostic Labs
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Academic & Research Institutes
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Biotechnology & Pharmaceutical Companies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
8. Global Biosimilar Pipeline Analysis Market, By Regions, 2021 – 2028 (US$ Million)
o Introduction
• Market Share Analysis, By Region, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, For Regions, 2021 – 2028
o North America
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• U.S.
• Canada
o Europe
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
o Asia Pacific
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of APAC
o Latin America
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• Brazil
• Mexico
• Rest of Latin America
o Africa
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• South Africa
• Central Africa
• North Africa
o Middle East
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• GCC
• Israel
• Rest of Middle East
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact US:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837